Vasodilator Agents - Therapeutic use
Research News and Information

Monday, November 23, 2009

Recurrent ventricular fibrillation due to coronary artery spasm immediately after ascending aorta replacement.

29 Sep 2009 Coronary artery spasm (CAS) is a dangerous complication during cardiac surgery, causing arduous weaning of extracorporeal circulation (ECC) and myocardial tissue loss with consequent left and right ventricular dysfunctions. We describe the case of a ... Read more...

Association between widowhood and risk of diagnosis with a sexually transmitted infection in older adults.

15 Sep 2009 OBJECTIVES: We assessed whether widowhood is associated with risk of diagnosis with a sexually transmitted infection (STI) among older adults in the United States and whether the associations observed in men differed before and after the ... Read more...

Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy.

12 Sep 2009 BACKGROUND: The currently recommended treatment for chronic thromboembolic pulmonary hypertension is pulmonary thromboendarterectomy (PTE). No convincing evidence for the use of pulmonary hypertensive medical therapy (PHT) exists in operable ... Read more...

Latest indexed articles for 'Vasodilator Agents - Therapeutic use'

These are the very latest articles for this heading:

• Dopexamine and survival: areas of consistency. 30 Oct 2009
• Recurrent ventricular fibrillation due to coronary artery spasm immediately after ascending aorta replacement. 29 Sep 2009
• Association between widowhood and risk of diagnosis with a sexually transmitted infection in older adults. 15 Sep 2009
• Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. 12 Sep 2009
• [Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding] 31 Aug 2009
• Current ESC/ESICM and ACCF/AHA guidelines for the diagnosis and management of acute heart failure in adults--are there differences? 30 Aug 2009
• Successful treatment of severe cerebral vasospasm following hemorrhage of an arteriovenous malformation. Case report. 30 Aug 2009
• Enhancement of amlodipine cardioprotection by quercetin in ischaemia/reperfusion injury in rats. 30 Aug 2009
• Adequate vascular repair is relevant to improving renal perfusion and function following vasodilators in normoalbuminuric type 2 diabetic nephropathy. 30 Aug 2009
• Levosimendan for calcium channel blocker poisoning in humans. 30 Aug 2009
• Penile rehabilitation. 30 Aug 2009
• Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report. 30 Aug 2009
• Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT). 29 Aug 2009
• [Combination therapy for the treatment of pulmonary arterial hypertension] 26 Aug 2009
• [Update: Current clinical developments in pulmonary hypertension] 26 Aug 2009
• [Update: Preclinical developments for the treatment of pulmonary arterial hypertension] 26 Aug 2009
• Evaluating patients with persistent chest pain and no obstructive coronary artery disease. 10 Aug 2009
• [Dyspnea secondary to pulmonary hypertension in a patient with splenic myeloid metaplasia] 9 Aug 2009
• Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil. 9 Aug 2009
• Mortality after first myocardial infarction in Greek patients: a 4-year follow-up study. 8 Aug 2009

See a longer list of these articles.

Technical information about 'Vasodilator Agents'

Definition: Drugs used to cause dilation of the blood vessels.

Registry Number: 0

Descriptor UI: D014665

Alternative terms: Vasodilator Agents; Agents, Vasodilator; Vasodilator Drugs; Drugs, Vasodilator; Vasodilators; Vasoactive Antagonists; Antagonists, Vasoactive;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.411.918;

Technical Notes: consider also VASOMOTOR SYSTEM /drug eff